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Supporting Information -Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants Section S1 -Sep-Pak Column Method Development
As stated in the main text, the first 10 mL of Sep-Pak ® eluent were discarded in order to remove impurities with quicker elution speeds than the final product. The discovery that some impurities eluted from the column before each final product was made when 1 H NMR spectra were obtained for four separate fractions that were collected from the elution of complex 1 through a Sep-Pak ® . The 1 H-195 Pt HMQC spectrum of the first fraction was also obtained ( Figure S1 .1). 2 ] is therefore likely to be this impurity. This is significant as previous Sep-Pak ® methodologies did not involve the discarding of any initial eluted solvent. 3 The 1 H NMR spectrum of the second fraction showed peaks corresponding to both complex 1 and the impurity in the first fraction, indicating that an overlap of elution had occurred. The 1 H NMR spectra of the 3 rd and 4 th fractions subsequently showed complex 1 only, with impurities at an acceptably low level (< 2%). Due to these results, subsequent Sep-Pak ® purifications followed the methodology described in the main text in which the first 10 mL to elute was discarded. The success of this methodology is seen in the 1 H NMR spectra of collected fractions of complex 2 ( Figure S1 .2). The collection of a larger volume in the first fraction resulted in some loss of final product, but ensured that subsequent fractions were acceptably pure. Supporting Information -Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants Supporting Information -Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants Supporting Information -Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants Supporting Information -Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants 
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